Regulatory movement | Insurance
Questions for the UK courts on Covid-19 and causation
Market-leading experts offering quality technical advice
Our occupational disease and legacy claims team handles thousands of claims each year. We are trusted partners to major composite, run-off and specialist insurers, self-insured companies, multinationals with captive cover and public sector bodies. Our global footprint allows us to monitor trends and developments of emerging risks for our clients and offer cross-border solutions.
We act in individual matters (pre- and post-litigation), long-tail and short-tail claims, group litigation, strategic litigation projects. We provide advice on handling policies, government consultations and costs.
Our expertise includes asbestos, asthma, lung disease, autoimmune disorders, back injuries, cancer, carbon monoxide poisoning, carpal tunnel syndrome, chemical and biological agent exposure, chronic obstructive pulmonary disease, dermatitis, hand-arm vibration syndrome, pneumoconiosis, upper limb disorders, respiratory diseases, work-related stress and noise-induced hearing loss. We manage product liability class actions and a significant volume of run-off disease claims.
Our innovative strategies reduce indemnity spending when handling long-tail and short-tail claims, most notably:
- Our 'pay and be paid' mesothelioma claims handling scheme
- Our diffuse pleural thickening asbestosis initiative, and
- Our strategic approach to immunotherapy.
Our partner-led service assures quality through technical expertise, bespoke case management and information provision. Our global partner network advises on comparative law, litigation and emerging risks and issues.
We work closely as thought leaders with industry bodies to shape the legacy and latent disease policy landscape. We keep clients up to date on the latest industry developments, helping them to prepare for changes that will impact their business. We regularly work with clients to build strategies to meet anticipated emerging risks, for example claims potential from the COVID-19 pandemic and dynamic Know Your Opponent strategies.
Brilliant. They are excellent technically, and get what our needs and desires are. They provide a tailored approach that works well for us"
Chambers and Partners, 2022